Adjuvant medical therapy for prostate cancer

Author： Sumey Christopher   Flaig Thomas W  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.1, 2011-01, pp. : 73-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bicalutamide as adjuvant therapy warranted in early prostate cancer

By  

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)--Agonist Therapy in Prostate Cancer

By Kaisary A.V.   Jarmulowicz M.  

UroOncology, Vol. 3, Iss. 2, 2003-06 ,pp. : 51-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adjuvant Therapy in Prostate Cancer: Patient Identification and Treatment Options

By Syed S.   Tolcher A.   Troyer D.   Furman J.   Leach R.   Thompson I.M.  

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 119-126

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Aminoglutethimide adjuvant therapy in breast cancer

By  

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Adjuvant Therapy for Rectal Cancer in the Elderly

By Cohen S.M.   Neugut A.I.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 437-451

Adis International

Access to resources Recommend Favorite